BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34676038)

  • 1. Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma.
    Kwong AJ; Pham TND; Oelschlager HE; Munshi HG; Scheidt KA
    ACS Med Chem Lett; 2021 Oct; 12(10):1559-1567. PubMed ID: 34676038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors.
    Deibler KK; Schiltz GE; Clutter MR; Mishra RK; Vagadia PP; O'Connor M; George MD; Gordon R; Fowler G; Bergan R; Scheidt KA
    ChemMedChem; 2019 Mar; 14(6):615-620. PubMed ID: 30707493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system.
    Flood DG; Finn JP; Walton KM; Dionne CA; Contreras PC; Miller MS; Bhat RV
    J Comp Neurol; 1998 Aug; 398(3):373-92. PubMed ID: 9714150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family.
    Deibler KK; Mishra RK; Clutter MR; Antanasijevic A; Bergan R; Caffrey M; Scheidt KA
    ACS Chem Biol; 2017 May; 12(5):1245-1256. PubMed ID: 28263556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
    Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
    J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.
    Swantek JL; Cobb MH; Geppert TD
    Mol Cell Biol; 1997 Nov; 17(11):6274-82. PubMed ID: 9343388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia.
    Delgado M
    Biochem Biophys Res Commun; 2002 May; 293(2):771-6. PubMed ID: 12054537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal localization of four MAPK signaling cascade genes: MEK1, MEK3, MEK4 and MEKK5.
    Rampoldi L; Zimbello R; Bortoluzzi S; Tiso N; Valle G; Lanfranchi G; Danieli GA
    Cytogenet Cell Genet; 1997; 78(3-4):301-3. PubMed ID: 9465908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.
    Lin MW; Tsao LT; Chang LC; Chen YL; Huang LJ; Kuo SC; Tzeng CC; Lee MR; Wang JP
    Biochem Pharmacol; 2007 Jun; 73(11):1796-806. PubMed ID: 17379190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers.
    Wang H; Chi L; Yu F; Dai H; Si X; Gao C; Wang Z; Liu L; Zheng J; Ke Y; Liu H; Zhang Q
    Bioorg Med Chem; 2022 Sep; 70():116922. PubMed ID: 35849914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges.
    Mishra RK; Deibler KK; Clutter MR; Vagadia PP; O'Connor M; Schiltz GE; Bergan R; Scheidt KA
    J Chem Inf Model; 2019 Oct; 59(10):4460-4466. PubMed ID: 31566378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
    Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
    J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines.
    Maeda N; Fu W; Ortin A; de las Heras M; Fan H
    J Virol; 2005 Apr; 79(7):4440-50. PubMed ID: 15767444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
    Van Swearingen AED; Sambade MJ; Siegel MB; Sud S; McNeill RS; Bevill SM; Chen X; Bash RE; Mounsey L; Golitz BT; Santos C; Deal A; Parker JS; Rashid N; Miller CR; Johnson GL; Anders CK
    Neuro Oncol; 2017 Oct; 19(11):1481-1493. PubMed ID: 28486691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers: Rational Strategies and Recent Progress.
    Ghanaatgar-Kasbi S; Khazaei M; Rastgar-Moghadam A; Ferns GA; Hassanian SM; Avan A
    Curr Cancer Drug Targets; 2020; 20(6):417-428. PubMed ID: 32329688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of microbial activated Aedes aegypti MEK4 (AaMEK4): influences of noncatalytic domains on enzymatic activity.
    Wu RC; Cho WL
    Insect Mol Biol; 2014 Oct; 23(5):644-55. PubMed ID: 25039995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.
    Spreafico A; Tentler JJ; Pitts TM; Tan AC; Gregory MA; Arcaroli JJ; Klauck PJ; McManus MC; Hansen RJ; Kim J; Micel LN; Selby HM; Newton TP; McPhillips KL; Gustafson DL; Degregori JV; Messersmith WA; Winn RA; Eckhardt SG
    Clin Cancer Res; 2013 Aug; 19(15):4149-62. PubMed ID: 23757356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of the mitogen-activated protein kinase signaling pathway in Hassall's corpuscles of the human thymus.
    Nishio H; Matsui K; Tsuji H; Tamura A; Suzuki K
    Acta Histochem; 2001 Feb; 103(1):89-98. PubMed ID: 11252631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.